How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors episode artwork

EPISODE · Mar 7, 2024 · 7 MIN

How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors

from NeuroFrontiers

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jagan Pillai, MD, PhD Cerebral amyloid angiopathy (CAA) is a common neurological change that frequently coexists with other pathologies like Alzheimer's disease and Lewy body dementia, which led a team of researchers to investigate the risk factors and prevalence of CAA. The study found that not only is age a risk factor for CAA, but CAA is also seen in patients with Lewy body pathology alone and in patients with both Alzheimer's disease and Lewy body pathology. Dive further into the findings with Dr. Charles Turck and Dr. Jagan Pillai, a behavioral neurologist at Cleveland Clinic Lou Ruvo Center for Brain Health.

Episode metadata supplied by the publisher feed · Published Mar 7, 2024

Embed this episode

Ready to play

How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors

0:00 7:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of NeuroFrontiers?

This episode is 7 minutes long.

When was this NeuroFrontiers episode published?

This episode was published on March 7, 2024.

Can I download this NeuroFrontiers episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!